Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy

NCT06666634 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Penile Cancer
Melanoma
Oral Cancer

Interventions

DRUG: Sentinel node biopsy with either ICG-99mTc-nanoscan or 99mTc-nanoscan

Sponsor

The Netherlands Cancer Institute